FDA Calls for Public Comment on Cannabis Rescheduling

fda

FDA officials have put out a call for public comment about the potential rescheduling of cannabis and several other substances.

The feds want specifically to hear about the substances’ “abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use.”

Continue reading “FDA Calls for Public Comment on Cannabis Rescheduling”